April 10th, 2024 - Headquartered in Bagsvaerd, Denmark, the pharmaceutical manufacturer Novo Nordisk has been producing Ozempic, a drug meant to keep type II diabetes under control, for nearly 20 years
It is produced by the liver and kidneys through the conversion of two essential amino acids: lysine and methionine
GLP-1 Medications and Thyroid Safety: What the Research Shows GLP-1 receptor agonists including semaglutide work by slowing stomach emptying, increasing feelings of fullness, and improving blood sugar controlmechanisms that are independent of thyroid function
Some users report less shedding
Patients who are taking GLP-1s for weight loss have the added risk of becoming deficient in nutrients that are needed for the health and integrity of the ocular surface, such as antioxidants, trace minerals, and vitamins D and C
Realistic expectation: Small but measurable improvements in glucose and lipid markers over 2-3 months